CLINICAL_TRIALS
trial_result
· 2013-02-20
Clinical Trial Update: Capecitabine and Oxaliplatin Adjuvant Study in Stomach Cancer [Phase 3]
Summary
Phase 3 adjuvant trial of capecitabine plus oxaliplatin for gastric cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Stomach Neoplasms | Phase 3 | Status: COMPLETED